Augmenix

Category Archives

Augmenix Receives FDA Clearance to Market its TraceIT™ Tissue Marker

Augmenix, Inc., an innovative medical technology company focused on utilizing hydrogel technology in the fields of tissue marking and radiation oncology, Read more...

Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix

Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix Agreement creates opportunity for improving outcomes in radiation Read more...

Augmenix Announces First Commercial Use of SpaceOAR™ System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy

Augmenix Announces First Commercial Use of SpaceOAR™ System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy WALTHAM, Read more...

Augmenix, Inc. Closes $6.1 Million Financing

WALTHAM, Mass., Oct. 16 /PRNewswire/ -- Augmenix announced today that it has closed a $6.1 million Series B financing. The round was led by Ascension Read more...

Page 3 of 3123

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184